{"name": "Rodos BioTarget",
 "permalink": "rodos-biotarget",
 "crunchbase_url": "http://www.crunchbase.com/company/rodos-biotarget",
 "homepage_url": "http://www.biotargeting.eu/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2008,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "RBT",
 "email_address": "info@biotargeting.eu",
 "phone_number": "49-(0)-176-3291-3096",
 "description": "Biopharmaceutical company ",
 "created_at": "Fri Apr 19 10:52:08 UTC 2013",
 "updated_at": "Fri Apr 19 11:02:14 UTC 2013",
 "overview": "\u003Cp\u003ERodos BioTarget (RBT) is a biopharmaceutical company developing a targeted drug delivery platform. RBT\u2019s patented TargoSphere\u00ae technology enables carrying a broad range of active agents selectively into the center of the immune response - i.e., directly into antigen-presenting cells.\u003C/p\u003E\n\n\u003Cp\u003ERBT currently applies its TargoSphere\u00ae technology successfully in various models of infectious diseases caused by viruses like HCV/ Hepatitis C and HIV/ AIDS and by bacteria like in Tuberculosis, Legionellosis, and MRSA. Yet, any disorder that goes along with either overshooting or insufficient immunity caused by antigen-presenting cells - like chronic inflammations, cancers, allergies, and autoimmune diseases - may be addressed by RBT\u2019s TargoSphere\u00ae technology.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[132,
       129],
      "assets/images/resized/0025/3058/253058v1-max-150x150.jpg"],
     [[132,
       129],
      "assets/images/resized/0025/3058/253058v1-max-250x250.jpg"],
     [[132,
       129],
      "assets/images/resized/0025/3058/253058v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac2.6M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2013/04/rodos-biotarget-raises-e2-6m-funding.html",
    "source_description": "Rodos BioTarget Raises \u20ac2.6M in Funding",
    "raised_amount": 2600000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Enjoyventure Management",
         "permalink": "enjoyventure-management",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0010/1960/101960v1-max-150x150.jpg"],
             [[220,
               84],
              "assets/images/resized/0010/1960/101960v1-max-250x250.jpg"],
             [[220,
               84],
              "assets/images/resized/0010/1960/101960v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "High-Tech Gruenderfonds",
         "permalink": "high-tech-gruenderfonds",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0002/8109/28109v4-max-150x150.jpg"],
             [[250,
               69],
              "assets/images/resized/0002/8109/28109v4-max-250x250.jpg"],
             [[450,
               125],
              "assets/images/resized/0002/8109/28109v4-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ERP Startfonds",
         "permalink": "erp-startfonds",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Medical Park Hannover",
    "address2": "Feodor-Lynen-Str. 23",
    "zip_code": "30625",
    "city": "Hannover",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        81],
       "assets/images/resized/0025/3061/253061v1-max-150x150.jpg"],
      [[250,
        135],
       "assets/images/resized/0025/3061/253061v1-max-250x250.jpg"],
      [[450,
        244],
       "assets/images/resized/0025/3061/253061v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}